HIV Essentials

The world's leading experts provide all the 'essentials' needed to manage HIV patients in the office, on the ward, and in the ICU. HIV Essentials incorporates the latest clinical guidelines into a step-by-step guide to the diagnosis, evaluation, management, and prevention of HIV infection and its complications. Topics include opportunistic infections and other HIV complications, treatment of HIV and pregnancy, antiretroviral drug summaries, post-exposure prophylaxis, as well as commercially available dosage forms for all ARVs. The Ninth Edition features updates to content and numerous tables to reflect the latest DHHS guidelines and the 2020 IAS-USA guidelines for HIV treatment.

Author: Paul E. Sax, Melanie Berry
Publisher: Jones & Bartlett Publishers
Published: 11/15/2021
Pages: 300
Binding Type: Paperback
Weight: 0.60lbs
Size: 6.46h x 4.72w x 0.79d
ISBN: 9781284223668

About the Author
Sax, Paul E.: - "Dr. Paul E. Sax is Clinical Director of the Division of Infectious Diseases at Brigham and Women's Hospital (BWH), where he holds the Bruce A. Beal and Robert L. Beal Distinguished Chair in Infectious Diseases, and Professor of Medicine at Harvard Medical School. Dr. Sax received his MD from Harvard Medical School, completed his residency in Internal Medicine at BWH, then fellowship in Infectious Diseases at Massachusetts General Hospital. He is Editor-in-Chief of Open Forum Infectious Diseases, is Section Editor of HIV/AIDS in UpToDate, on the Editorial Board of NEJM Journal Watch Infectious Diseases (where he writes the HIV and ID Observations blog), and on the editorial advisory board of Medscape HIV/AIDS. Dr. Sax is the Associate Program Director for the Mass General Brigham fellowship in Infectious Diseases, is on the core faculty of the International Antiviral Society - USA, and teaches regularly on HIV and infectious diseases locally, nationally, and internationally. In addition to his clinical practice and teaching, Dr. Sax's ongoing areas of research include clinical trials of antiretroviral therapies, cost-effectiveness of management strategies for HIV, and toxicity of antiretroviral therapy. He is presently the principal investigator at the BWH AIDS Clinical Trials Unit, and is a member of the Cost Effectiveness of Preventing AIDS Complications (CEPAC) Research Group."Berry, Melanie: - Melanie Berry, PharmD, BCACP, is a Clinical Ambulatory Pharmacist at Beth Israel Deaconess Medical Center (BIDMC). Dr. Berry graduated with her Doctorate in Pharmacy from University of Missouri-Kansas City School of Pharmacy. She completed a PGY1 residency in Community Pharmacy at Cleveland Clinic and a PGY2 residency in Ambulatory Care at Boston Medical Center. She is a board certified Ambulatory Care pharmacist. Dr. Berry's focus is in HIV and Pre-Exposure Prophylaxis (PrEP) at Healthcare Associates, a primary care clinic at BIDMC. She started and runs a pharmacist-run PrEP clinic based on a collaborative practice with a supervising physician to prescribe to and monitor PrEP patients.